Literature DB >> 2797213

Selective local action of angiotensin II on dopaminergic neurons in the rat hypothalamus in vivo.

E Badoer1, H Würth, D Türck, F Qadri, K Itoi, P Dominiak, T Unger.   

Abstract

Microdialysis was used to investigate whether angiotensin II modulates the basal and K+-induced release of endogenous noradrenaline, dopamine and their metabolites 3,4-dihydroxyphenylglycol (DOPEG) and 3,4-dihydroxyphenylacetic acid (DOPAC) from the anterior hypothalamus of the anaesthetized rat. The release of the amines was stimulated twice (ST1 and ST2) with either 50 mmol/l or 100 mmol/l K+. The release of each amine induced by K+ was reproducible and concentration-dependent. Angiotensin II when present in the perfusion fluid after ST1 at a concentration of 0.1 and 10 mumol/l (chosen after in vitro experiments had shown that the recovery of the peptide across the dialysis membrane was only 3.6%), had no significant effect on amine release. However, 10 mumol/l angiotensin II induced an immediate, significant increase in basal DOPAC outflow which reached a maximum of 89% in the 100 mmol/l K+ and 53% in the 50 mmol/l K+ experiments. No such effect was observed with DOPEG outflow. In a separate experimental series, addition of angiotensin II without a preceding K+ stimulation period did not significantly affect the outflow of the amines and metabolites. The results suggest that angiotensin II can selectively influence dopamine metabolism in the anterior hypothalamus in vivo but does not act locally to acutely facilitate the release of endogenous catecholamines from this brain area.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797213     DOI: 10.1007/bf00169203

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Presynaptic receptor systems on the noradrenergic neurones of rat brain.

Authors:  H D Taube; K Starke; E Borowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

2.  Angiotensin II facilitates the potassium-evoked release of 3H-noradrenaline from the rabbit hypothalamus.

Authors:  J A Garcia-Sevilla; M L Dubocovich; S Z Langer
Journal:  Eur J Pharmacol       Date:  1979-06       Impact factor: 4.432

3.  Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

Authors:  K Kuschinsky; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

Review 4.  Functions of angiotensin in the central nervous system.

Authors:  M I Phillips
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

5.  Effects of angiotensin II and ACE inhibitors on electrically stimulated noradrenaline release from superfused rat brain slices.

Authors:  U Schacht
Journal:  Clin Exp Hypertens A       Date:  1984

6.  Factors influencing the release of noradrenaline from hypothalamic slices of the possum, Trichosurus vulpecula.

Authors:  J B Minson; I S de la Lande
Journal:  Aust J Exp Biol Med Sci       Date:  1984-06

7.  Plasma angiotensin II: dipsogenic levels and angiotensin-generating capacity of renin.

Authors:  J F Mann; A K Johnson; D Ganten
Journal:  Am J Physiol       Date:  1980-05

8.  Central injection of angiotensin II alters catecholamine activity in rat brain.

Authors:  C Sumners; M I Phillips
Journal:  Am J Physiol       Date:  1983-02

9.  Angiotensin II inhibits the K+-evoked release of [3H]norepinephrine from hypothalamic synaptosomes of the spontaneously hypertensive rat.

Authors:  D F Bottiglieri; C Sumners; M K Raizada
Journal:  Brain Res       Date:  1987-02-10       Impact factor: 3.252

10.  Norepinephrine uptake by rat jejunum: modulation by angiotensin II.

Authors:  A Suvannapura; N R Levens
Journal:  Am J Physiol       Date:  1988-02
View more
  1 in total

1.  Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.

Authors:  Kazushi Tsuda
Journal:  Int J Hypertens       Date:  2012-11-21       Impact factor: 2.420

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.